Quantitative Lung Ultrasonography to Guide Surfactant Therapy in Neonates Born Late Preterm and Later
JAMA Network Open · 28.05.2024 · 7 (5) · e2413446
DOI: 10.1001/jamanetworkopen.2024.13446 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JAMA Network Open, online erschienen am 28.05.2024. Verfasst von Daniele De Luca und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatrics and Neonatal Critical Care, "A. Béclère" Hospital, AP-HP-Paris Saclay University, Paris, France. Hauptthemen laut MEDLINE: Pulmonary Surfactants, Infant, Premature, Ultrasonography, Lung. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Surfactant administration may be needed in late preterm through full-term neonates, but the pathophysiology of their respiratory failure can be different from that of early preterm neonates. The lung ultrasonography score (LUS) is accurate to guide surfactant replacement in early preterm neonates, but to our knowledge, it has not yet been studied in the late preterm through full-term neonatal population.
Objective
To assess whether LUS is equally accurate to predict surfactant need in late preterm through full-term neonates as in early preterm neonates. Design, Setting, and Participants This prospective, international, multicenter diagnostic study was performed between December 2022 and November 2023 in tertiary academic neonatal intensive care units in France, Italy, Spain, and the US. Late preterm through full-term neonates (≥34 weeks’ gestation) with respiratory failure early after birth were enrolled. Exposure Point-of-care lung ultrasonography to calculate the neonatal LUS (range, 0-18, with higher scores indicating worse aeration), which was registered in dedicated research databases and unavailable for clinical decision-making. Main Outcomes and Measures The main outcomes were the area under the curve (AUC) in receiver operating characteristic analysis and derived accuracy variables, considering LUS as a replacement for other tests (ie, highest global accuracy) and as a triage test (ie, highest sensitivity). Sample size was calculated to assess noninferiority of LUS to predict surfactant need in the study population compared with neonates born more prematurely. Correlations of LUS with the ratio of hemoglobin oxygen saturation as measured by pulse oximetry (SpO 2 ) to fraction of inspired oxygen (FiO 2 ) and with the oxygen saturation index (OSI) were assessed.
Results
A total of 157 neonates (96 [61.1%] male) were enrolled and underwent lung ultrasonography at a median of 3 hours (IQR, 2-7 hours) of life; 32 (20.4%) needed surfactant administration (pretest probability, 20%). The AUC was 0.87 (95% CI, 0.81-0.92). The highest global accuracy and sensitivity were reached for LUS values higher than 8 or 4 or lower, respectively. Subgroup analysis gave similar diagnostic accuracy in neonates born late preterm (AUC, 0.89; 95% CI, 0.81-0.97; n = 111) and early term and later (AUC, 0.84; 95% CI, 0.73-0.96; n = 46). After adjusting for gestational age, LUS was significantly correlated with SpO 2 :FiO 2 (adjusted β, −10.4; 95% CI, −14.0 to −6.7; P < .001) and OSI (adjusted β, 0.2; 95% CI, 0.1-0.3; P < .001). Conclusions and Relevance In this diagnostic study of late preterm through full-term neonates with respiratory failure early after birth, LUS accuracy to predict surfactant need was not inferior to that observed in earlier preterm neonates. An LUS higher than 8 was associated with highest global accuracy (replacement test), suggesting that it can be used to guide surfactant administration. An LUS value of 4 or lower was associated with the highest sensitivity (triage test), suggesting it is unlikely for this population to need surfactant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Pediatrics and Neonatal Critical Care, "A. Béclère" Hospital, AP-HP-Paris Saclay University, Paris, France.
- Physiopathology and Therapeutic Innovation Unit-INSERM U999, Paris Saclay University, Paris, France.
- Neonatal Intensive Care Unit, Department of Women's and Children's Health, University Hospital of Padova and Institute of Pediatric Research "Città della Speranza," Padua, Italy.
- Neonatal Intensive Care Unit, Puerta del Mar University Hospital, Cádiz, Spain.
- Biomedical Research and Innovation Institute of Cádiz (INiBICA), Research Unit, Puerta del Mar University Hospital, Cádiz, Spain.
- Department of Pediatrics, Division of Neonatal and Developmental Medicine, Stanford University, School of Medicine, Palo Alto, California.
Zitieren
APA
De Luca, D., Bonadies, L., Alonso-Ojembarrena, A., Martino, D., Gutierrez-Rosa, I., Loi, B., Dasani, R., Capasso, L., Baraldi, E., Davis, A., & Raimondi, F. (2024). Quantitative Lung Ultrasonography to Guide Surfactant Therapy in Neonates Born Late Preterm and Later. JAMA Network Open, 7(5), e2413446. https://doi.org/10.1001/jamanetworkopen.2024.13446
Vancouver
De Luca D, Bonadies L, Alonso-Ojembarrena A, Martino D, Gutierrez-Rosa I, Loi B, et al. Quantitative Lung Ultrasonography to Guide Surfactant Therapy in Neonates Born Late Preterm and Later. JAMA Network Open. 2024;7(5):e2413446. doi:10.1001/jamanetworkopen.2024.13446
BibTeX
@article{DeLuca2024,
author = {De Luca, Daniele and Bonadies, Luca and Alonso-Ojembarrena, Almudena and Martino, Diletta and Gutierrez-Rosa, Irene and Loi, Barbara and Dasani, Reedhi and Capasso, Letizia and Baraldi, Eugenio and Davis, Alexis and Raimondi, Francesco},
title = {Quantitative Lung Ultrasonography to Guide Surfactant Therapy in Neonates Born Late Preterm and Later},
journal = {JAMA Network Open},
year = {2024},
volume = {7},
number = {5},
pages = {e2413446},
doi = {10.1001/jamanetworkopen.2024.13446}
}
EUVIMED